sBMYear=2024 and sBMMonth=4
sCurrentPeriodOrder=220 for period=April,2024
FertAid/IVFCPD-List of Webinars.
Open Subscriptions and Cart Status
IVFCPD Webinars and Podcasts
 
  Chapters
Clinical Female
Clinical Male
ART Treatment
Patient Care
Embryology
Andrology
Nursing and Counselling
Quality/Clinic Management
Basic science/Training
Products/Groups/News
 
Webinars
Podcasts
Filter
IVF Worldwide
Cooper Surgical
FUJIFILM Irvine Scientific
Irvine Scientific
SART FERTILITY EXPERTS
The International IVF Initiative - i3
VITROLIFE
  SOURCES
II3
Cooper Surgical
CS Podcasts
FujiFilm Irvine
SART Podcasts
Vitrolife
IVF Worldwide
 
 
 
 
Webinar List  
  ID Name            
187 Engaging Australian males in healthy lifestyles   1
186 Adrenal Hyperandrogenism - ASPIRE   1
185 EXTREME IVF- I3 SESSION 127   0
184 CELLF CONTROL - I3 SESSION 126   0
183 FERTILIZATION- WHAT MATTERS? #SESSION 125   21
182 ART IN AFRICA . # SESSION 124   18
181 WHEN DISASTER STRIKES. #SESSION 123   19
180 NAVIGATING INTERNATIONAL SURROGACY #Session 122   18
179 TRACE ELEMENTS. #Session 121   10
178 CROSSOVER # Session 120   19
177 RBMO LIVE: Episode V   35
176 RBMO Live: Episode IV   29
175 RBMO LIVE: Episode III   30
174 KPIs - keep plodding indefinitely or keep performing impeccably?!   35
173 RBMO LIVE: EPISODE II   32
172 RBMO LIVE #1   30
171 When to Stop Storage: Improving Conversations About Unused Embryos   43
170 Your Guide to Genetics and Genomics in the Fertility Clinic   49
169 Counselling and Assisted Reproduction: When, Why and by Whom Should It Be Offered?   52
168 Session 69: The embryo in culture: Imprinting, oxidative stress and epigentic changes.   81
167 Session 71: Generations   51
166 Paternal aging and spontaneous mutations in the embryo: potential causes and consequences   57
165 The busines of operating multiple ART laboratories.   47
164 A Review: When to Transfer and What To Transfer?   47
163 New strategies to optimize ovarian stimulation for IVF/ICSI: a window to the future   51
162 How an Unlikely Technology became Routine Fertility Treatment: Remembering the First Pioneers of IVF   53
161 The clinical impact of next generation sequencing NGS in reproductive medicine   76
160 The potential of in vitro maturation of primordial (non-growing) follicles   58
159 Why and how to supplement androgens in infertile women?   98
158 Are we ready for clinical applications of the nuclear transfer technique?   63
157 A discussion with Prof. Klaus Dugi, EVP and Chief Medical Officer at Ferring Pharmaceuticals   55
156 Fertility preservation and endometriosis   53
155 Ovarian Endometrioma related to infertility: Surgery of IVF first?   53
154 AMH: the importance of its clinical use   78
153 Ovary transplant and IVM to preserve fertility in young cancer patients   51
152 Progesterone – Mode of Action   68
151 How to define successful IVF   79
150 The clinical aspects of the different formulation of progesterone   101
149 Progesterone supplementation: Effects & optimization of duration on live IVF/ICSI birth rates   84
148 Fertility preservation in women: Where are we in 2020?   54
147 Implantation: the rold of the embryo and the enometrium   57
146 Optimizing Endometrial Preparation for Frozen Embryo Transfer   63
145 A fertility center in NYC going through COVID-19, economic depression and riots   75
144 The Danish Fertility Preservation Programme   54
143 Progestin Primed Ovarian Stimulation   51
142 Fresh and Frozen: When and Why?   55
141 Sperm selection with hyaluronic acid improved live birth outcomes   48
140 How to streamline your workflow and secure good results with oocyte vitrification. [Vitrolife]   50
139 Retrospective clinical dataset of 7000 warmed blastocysts with an optimised, closed vitrification system [Vitrolife]   50
138 Closed and open carrier devices for vitrification [Vitrolife]   50
137 Antioxidants in Human IVF - an innovation in culture media. [Vitrolife]   50
136 Oil in IVF CUlture - a ligth or heavy oil decision. [Vitrolife]   57
135 Latest technologies in embryo selection [Vitrolife]   54
134 iDA Score - Changing the paradigm of embryo evaluation.   43
133 Past, Present and Future of Time-lapse in clinical IVF   74
132 Breaking new ground in embryo evalution   77
131 If quality is your outcome, then governance must be your business [NATA]   60
130 Why you should “risk” everything [NATA]   50
129 Is your laboratory future fit? What can be done today to be ready for tomorrow? [NATA]   50
128 Accreditation in the crosshairs [NATA]   50
127 FAMOUS   50
126 A Review: When to Transfer and What To Transfer?   54
125 This Changes Everything: A Fundamental Shift in Embryo Culture   100
124 Life Whisperer Viability Webinar Series webinar 3   50
123 Life Whisperer Viability Webinar Series webinar 2   53
122 Life Whisperer Viability Webinar Series webianr 1.   53
121 Basic Conditions for the Transport of Vitrified Specimens   55
120 Behind the Scenes of Media Development   51
119 Trending Topics Within the IVF Laboratory   59
118 Everything You Wanted to Know About Vitrification Media but Didn’t Know Who to Ask   52
117 3 Tips to Simplify 3 Procedures in the IVF Lab   105
116 Closed System Vitrification, What have we learned so far?   52
115 Vitrification Media Composition - The Important Roles of the Components   51
114 MEGA - Technical Aspects of How & Why It Works   55
113 Sperm Cryopreservation Update: Cryodamage, Markers, and Factors Affecting Sperm Freezing   41
112 Critical Parameters of IVF   82
111 The curious case of lactate, a blastocyst and an endometrium   63
110 SPERM-DRIVEN AND SPERM-TEMPLATED MICROROBOTS   43
109 AI facial matching for gamet donors and recipients.   64
108 The emotional experience of infertility and how we can support our patients.   54
107 Mechanistic analysis of sperm selection with hyaluronic acid and treatment outcomes   66
106 Using electronic witnessing to minimize IVF errors   53
105 Quality control in the clouds.   55
104 Paternal Aging and spontaneous mutations in the embryo: potential causes and consequencesQUENCES   60
103 THE ART OF CONSERVING ENDANGERED SPECIES   85
102 Live from PGDIS with our genomics experts   58
101 ICSI - Past, Present & Future   57
100 BRILLIANT MINDS: NEW APPROACHES IN ART AND FERTILITY TREATMENT   57
99 The-importance-of-quality-control-in-the-human-ivf-laboratory   51
98 ZYMOT FERTILITY SYMPOSIA   57
97 ERA Online Panel discussion - How to prepare a healthy endometrium?   60
96 pH Deep Dive   56
95 INTRODUCTION TO QUALITY CONTROL - PART II   50
94 INTRODUCTION TO QUALITY CONTROL - PART 1   51
93 I3 GOES MAVERICK -The Maverick Reproductive Biologist-Oil overlayis in IVF   53
92 Artificial Intelligence in ART   90
91 KEEP PLODDING INDEFINITELY OR KEEP PERFORMING IMPECCABLY?!   103
90 Driving efficiencies in IVF upwards.   98
89 The human Y chromosome and the future of men.   55
88 MINDING THE GAPS: REFLECTING ON THE STATE OF EMBRYOLOGISTS   53
87 RECALCULATION: HOW MANY EMBRYOLOGISTS DO I NEED?   47
86 Oocyte pick up: How to prepare patients   56
85 Oocyte pick-up: Laboratory standards and recommendations   53
84 Oocyte pick up: Advice on clinical team communication   48
83 How RI Witness can help prevent mismatches   63
82 Electronic Witnessing: Lessons over ten years   60
81 Fertility preservation for cancer patients: In Vitro Maturation (IVM) and its role in oncofertility   53
80 Fertility preservation for cancer patients: The possible bright future of in-vitro maturation (IVM) and patient outcomes   55
79 PATERNAL AGING AND SPONTANEOUS MUTATIONS IN THE EMBRYO: POTENTIAL CAUSES AND CONSEQUENCES   57
78 PRECISION MEDICINE IN REPRODUCTION: TIME FOR PREDICTION AND PREVENTION   51
77 Factors influencing success in donor IUI for lesbian and single women - the clinic   86
76 Factors influencing success in donor IUI for lesbian and single women - the laboratory   65
75 The Chamber of Secrets- Endometrial Preparation and Embryo Transfer   52
74 Implantation: the rold of the embryo and the endometrium   63
73 Embryo selection with artificial intelligence: how to evaluate and compare methods   79
72 Artificial shrinkage for blastocyst vitrification   51
71 Why does osmolality matter? Observations, drift, explanations, and counter   83
70 Laboratory Planning, Maintenance and Engineering Now and in the Future   55
69 New England Fertility Society VIRTUAL MEETING SERIES ~ Part I   84
68 How to Keep Gametes and Embryos from Environmental Harm   42
67 Assisted Reproductive Technology in Endangered Species Conservation   54
66 Preimplantation Genetic Testing, Recent Advances in Reproductive Medicine   57
65 What Genomics Dreams Might Come   41
64 Secrets of Implantation   56
63 The Maribor consensus: report of an expert meeting on the development of performance indicators for clinical practice in ART   55
62 Evidence based best practice in ooctye pick-up: a clinical perspective   52
61 MIGHTY MOLECULES IN REPRODUCTION   76
60 Managing Quality in the ART Laboratory   77
59 PGT-A in the Lab - Improving Outcomes and Techniques   57
58 The future of embryology. Technological advant-gardes in embryo selection   52
57 Why and how to supplement androgens in infertile women?   86
56 Principles of Cryopreservation and Optimization of Vitrification   54
55 CRYOGOVERNANCE IV   55
54 Demystifying mosaicism: The future   74
53 Demystifying mosaicism: Innovation and technology   66
52 Demystifying mosaicism: Where did it all begin?   60
51 Marginal Gains 3: Optimising culture conditions   54
50 Marginal gains 2: Dish set-up   55
49 Marginal gains: An introduction to the principles of marginal gains and its application in the IVF lab   57
48 Fertility preservation for cancer patients: optimizing oocyte recovery for IVM   53
47 WHO laboratory manual for the examination and processing of human semen   57
46 Evidence based best practice in embryo transfer   57
45 Optimizing your embryo culture system   53
44 More or Less   53
43 Cryogovernance II   57
42 CRYOGOVERNANCE III: THIN ICE   57
41 What to really expect from oocyte vitrifcation   53
40 IVFCPDVIDEO- Viotti   64
39 IVF in the Time of COVID-19   59
38 3 Tips to Simplify 3 Procedures in the IVF Lab   107
37 Critical Parameters of IVF   54
36 Cryogovernance   47
35 Basic Conditions for the Transport of Vitrified Specimens   83
34 SART Fertility Experts - Your Infertility Nurse: Partner in Your Care   53
33 SART Fertility Experts - Behind the Scenes in the IVF Lab   101
32 Piezo_ICSI Hiraoka   49
31 MOVING SPERM FORWARD   55
30 Laboratory Controlled Factors Impacting IVF Culture Media Performance   56
29 Evaluation of IVF laboratory outcomes with key performance indicators   75
28 KPI CARE   55
27 LEGACY PART 1: RECRUITMENT, TRAINING, TALENT MANAGEMENT AND SUCCESSION PLANNING   54
26 LEGACY PART2 : RECRUITMENT, TRAINING, TALENT MANAGEMENT AND SUCCESSION PLANNING   54
25 AI, UNDER THE HOOD   52
24 RBMO VI   71
23 Recruitment, Training, Talent Management, and Succession Planning   111
22 PRISON AND ASSISTED REPRODUCTION   55
21 THE MINISTRY OF EMBRYOLOGY AND IMPLANTATION: DYNAMICS OF EMBRYO DEVELOPMENT I   52
20 Dynamic studies of embryo development in post-fertilization period - Implications for time lapse AI   52
19 The Role of the Y Chromosome in Infertility   58
18 THE ROLE OF THE Y CHROMOSOME IN INFERTILITY   59
17 Creating a Greener Clinic, The Triple Bottom Line   68
16 How Green is Your IVF?   76
15 Plastic Use in the IVF Lab   60
14 SUPPLY AND DEMAND: PERMANENT OF PER DIEM EMBRYOLOGISTS?   48
13 Minding the Gaps: Reflecting on the State of Embryologists   52
12 The nature of what we do or the excuse   108
11 THE INVISIBLE MALE   81
10 SESSION 107: HIGHLIGHTS OF THE 13TH BIENNIAL ALPHA CONGRESS   66
9 SESSION 108: EMBRIOLOGIA!   53
8 SESSION 110 : EXPLORING STRATEGIES TO IMPROVE FEMALE FERTILITY   55
7 SESSION 112 : THE INTELLIGENT SPERM   58
6 SESSION 113 : EMBRYOLOG   91
5 BEYOND THE WEBINAR - EMBRYO BIOPSY - LEVEL UP   88
4 Moving Sperm Forward   56
3 Laboratory Controlled Factors Impacting IVF Culture Media Performance   55
2 Evaluation of IVF laboratory outcomes with key performance indicators   54
1 Workflow efficiency related to iDAScore - Marcos Meseguer   78
 
Copyright IVFCPD Pty Ltd
Contact IVFCPD at Office@ivfcpd.com